866-997-4948(US-Canada Toll Free)

VolitionRX Ltd. (VNRX) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Dec 2012

Category :

Surgical Equipment

No. of Pages : 34 Pages


VolitionRX Ltd. (VolitionRX) is a life sciences company. The company makes non invasive blood tests for cancer. It provides NuQ suite of products: NuQ-X, NuQ-V, NuQ-M, NuQ-A and NuQ-CD. NuQ is a suite of epigenetic blood-based cancer diagnostics. The NuQ is based on proprietary Nucleosomics technology. The other products includes HyperGenomics and Endometriosis. The company plans to sells it products first in Europe and then in the US market. VolitionRX is headquatered in Singapore.

The company aims to broaden the development and production of full suite of epigenetic products under the NUQ brand name. It has also started clinical trial and validations to begin the process of obtaining approval for clinical use.

This report is a source for data, analysis and actionable intelligence on the VolitionRX Ltd. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 4

Key Facts 5
VolitionRX Ltd. - Major Products and Services 6
VolitionRX Ltd. Pipeline Products by Equipment Type 7
VolitionRX Ltd. Pipeline Products by Development Stage 9
HyperGenomics Diagnostic Test - Colon Cancer 11
HyperGenomics Diagnostic Test - Colon Cancer Product Status 11
HyperGenomics Diagnostic Test - Colon Cancer Product Description 11
HyperGenomics Diagnostic Test - Leukaemia 12
HyperGenomics Diagnostic Test - Leukaemia Product Status 12
HyperGenomics Diagnostic Test - Leukaemia Product Description 12
HyperGenomics Diagnostic Test - Prostate Cancer 13
HyperGenomics Diagnostic Test - Prostate Cancer Product Status 13
HyperGenomics Diagnostic Test - Prostate Cancer Product Description 13
NuQ Diagnostic Test - Colorectal Cancer 14
NuQ Diagnostic Test - Colorectal Cancer Product Status 14
NuQ Diagnostic Test - Colorectal Cancer Product Description 14
NuQ Diagnostic Test - Colorectal Cancer Product Patent Details 14
NuQ Diagnostic Test - Lung Cancer 16
NuQ Diagnostic Test - Lung Cancer Product Status 16
NuQ Diagnostic Test - Lung Cancer Product Description 16
NuQ Diagnostic Test - Lung Cancer Product Patent Details 16
NuQ Diagnostic Test - Pancreatic Cancer 18
NuQ Diagnostic Test - Pancreatic Cancer Product Status 18
NuQ Diagnostic Test - Pancreatic Cancer Product Description 18
NuQ Endo 19
NuQ Endo Product Status 19
NuQ Endo Product Description 19
NuQ Endo Product Patent Details 19
NuQ-B 21
NuQ-B Product Status 21
NuQ-B Product Description 21
NuQ-B Product Patent Details 21
NuQ-IHC 23
NuQ-IHC Product Status 23
NuQ-IHC Product Description 23
NuQ-M 24
NuQ-M Product Status 24
NuQ-M Product Description 24
NuQ-V 25
NuQ-V Product Status 25
NuQ-V Product Description 25
NuQ-X 26
NuQ-X Product Status 26
NuQ-X Product Description 26
VolitionRX Ltd. - Key Competitors 27
VolitionRX Ltd. - Key Employees 28
VolitionRX Ltd. - Locations And Subsidiaries 29
Head Office 29
Recent Developments 30
VolitionRX Ltd., Recent Developments 30
Dec 17, 2012: Volition Launches NuQ Epigenetic Immunoassays For Research Use 30
Aug 21, 2012: VolitionRX To Begin Prospective Clinical Trial In Colon Cancer 30
Feb 17, 2012: Volition Signs Collaboration Agreement With Abcodia 31
Dec 22, 2011: VolitionRX Intellectual Property Update: New Patent Filed 31
Sep 15, 2011: Volition Files Three New Patents In Europe And US 32
Jun 10, 2011: Volition Acquires Patent For Endometriosis Diagnostic Technology 32
Apr 18, 2011: Volition Appoints Habib Skaff To Scientific Advisory Board 32
Mar 28, 2011: Volition Announces Management Changes 33
Mar 18, 2011: Volition Opens Belgian Office And Lab Facilities In Namur, Wallonia 33

Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Table


VolitionRX Ltd., Key Facts 1
VolitionRX Ltd. Key Pipeline Products by Equipment Type 1
VolitionRX Ltd. Key Pipeline Products by Development Stage 1
VolitionRX Ltd., Key Facts 5
VolitionRX Ltd., Major Products and Services 6
VolitionRX Ltd. Number of Pipeline Products by Equipment Type 7
VolitionRX Ltd. Pipeline Products by Equipment Type 8
VolitionRX Ltd. Number of Pipeline Products by Development Stage 9
VolitionRX Ltd. Pipeline Products by Development Stage 10
HyperGenomics Diagnostic Test - Colon Cancer - Product Status 11
HyperGenomics Diagnostic Test - Colon Cancer - Product Description 11
HyperGenomics Diagnostic Test - Leukaemia - Product Status 12
HyperGenomics Diagnostic Test - Leukaemia - Product Description 12
HyperGenomics Diagnostic Test - Prostate Cancer - Product Status 13
HyperGenomics Diagnostic Test - Prostate Cancer - Product Description 13
NuQ Diagnostic Test - Colorectal Cancer - Product Status 14
NuQ Diagnostic Test - Colorectal Cancer - Product Description 14
NuQ Diagnostic Test - Colorectal Cancer - Patent Details1 14
NuQ Diagnostic Test - Lung Cancer - Product Status 16
NuQ Diagnostic Test - Lung Cancer - Product Description 16
NuQ Diagnostic Test - Lung Cancer - Patent Details1 16
NuQ Diagnostic Test - Pancreatic Cancer - Product Status 18
NuQ Diagnostic Test - Pancreatic Cancer - Product Description 18
NuQ Endo - Product Status 19
NuQ Endo - Product Description 19
NuQ Endo - Patent Details1 19
NuQ-B - Product Status 21
NuQ-B - Product Description 21
NuQ-B - Patent Details1 21
NuQ-IHC - Product Status 23
NuQ-IHC - Product Description 23
NuQ-M - Product Status 24
NuQ-M - Product Description 24
NuQ-V - Product Status 25
NuQ-V - Product Description 25
NuQ-X - Product Status 26
NuQ-X - Product Description 26
VolitionRX Ltd., Key Employees 28

List of Chart


VolitionRX Ltd. Key Pipeline Products by Equipment Type 1
VolitionRX Ltd. Pipeline Products by Equipment Type 7
VolitionRX Ltd. Pipeline Products by Development Stage 9

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *